Abstract
The ability to manipulate capripoxvirus through gene knockouts and gene insertions has become an increasingly valuable research tool in elucidating the function of individual genes of capripoxvirus, as well as in the development of capripoxvirus-based recombinant vaccines. The homologous recombination technique is used to generate capripoxvirus knockout viruses (KO), and is based on the targeting a particular viral gene of interest. This technique can also be used to insert a gene of interest. A protocol for the generation of a viral gene knockout is described. This technique involves the use of a plasmid which encodes the flanking sequences of the regions where the homologous recombination will occur, and will result in the insertion of an EGFP reporter gene for visualization of recombinant virus, as well as the E. coli gpt gene as a positive selection marker. If an additional gene is to be incorporated, this can be achieved by inserting a gene of interest for expression under a poxvirus promoter into the plasmid between the flanking regions for insertion. This chapter describes a protocol for generating such recombinant capripoxviruses.
Key words
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Boshra H, Truong T, Nfon C et al (2013) Capripoxvirus-vectored vaccines against livestock diseases in Africa. Antiviral Res. doi:10.1016/j.antiviral.2013.02.016
Tulman ER, Afonso CL, Lu Z et al (2001) Genome of lumpy skin disease virus. J Virol 75:7122–7130. doi:10.1128/JVI.75.15.7122-7130.2001
Tulman ER, Afonso CL, Lu Z et al (2002) The genomes of sheeppox and goatpox viruses. J Virol 76:6054–6061
Babiuk S, Bowden TR, Boyle DB et al (2008) Capripoxviruses: an emerging worldwide threat to sheep, goats and cattle. Transbound Emerg Dis 55:263–272. doi:10.1111/j.1865-1682.2008.01043.x
Bhanuprakash V, Indrani BK, Hosamani M et al (2006) The current status of sheep pox disease. Comp Immunol Microbiol Infect Dis 29:27–60. doi:10.1016/j.cimid.2005.12.001
Bowden TR, Babiuk SL, Parkyn GR et al (2008) Capripoxvirus tissue tropism and shedding: a quantitative study in experimentally infected sheep and goats. Virology 371:380–393. doi:10.1016/j.virol.2007.10.002
African Union International Bureau for Animal Resources (2012) Impact of livestock diseases in Africa, May
Davies FG, Mbugwa G (1985) The alterations in pathogenicity and immunogenicity of a Kenya sheep and goat pox virus on serial passage in bovine foetal muscle cell cultures. J Comp Pathol 95:565–572
Kitching RP (2003) Vaccines for lumpy skin disease, sheep pox and goat pox. Dev Biol (Basel) 114:161–167
Johnston JB, McFadden G (2004) Technical knockout: understanding poxvirus pathogenesis by selectively deleting viral immunomodulatory genes. Cell Microbiol 6:695–705. doi:10.1111/j.1462-5822.2004.00423.x
Balinsky CA, Delhon G, Afonso CL et al (2007) Sheeppox virus kelch-like gene SPPV-019 affects virus virulence. J Virol 81:11392–11401, JVI.01093-07 [pii]
Perrin A, Albina E, Breard E et al (2007) Recombinant capripoxviruses expressing proteins of bluetongue virus: evaluation of immune responses and protection in small ruminants. Vaccine 25:6774–6783. doi:10.1016/j.vaccine.2007.06.052
Wade-Evans AM, Romero CH, Mellor P et al (1996) Expression of the major core structural protein (VP7) of bluetongue virus, by a recombinant capripox virus, provides partial protection of sheep against a virulent heterotypic bluetongue virus challenge. Virology 220:227–231. doi:10.1006/viro.1996.0306
Soi RK, Rurangirwa FR, McGuire TC et al (2010) Protection of sheep against Rift Valley fever virus and sheep poxvirus with a recombinant capripoxvirus vaccine. Clin Vaccine Immunol 17:1842–1849
Wallace DB, Ellis CE, Espach A et al (2006) Protective immune responses induced by different recombinant vaccine regimes to Rift Valley fever. Vaccine 24:7181–7189. doi:10.1016/j.vaccine.2006.06.041, S0264-410X(06)00769-9 [pii]
Romero CH, Barrett T, Kitching RP et al (1995) Protection of goats against peste des petits ruminants with recombinant capripoxviruses expressing the fusion and haemagglutinin protein genes of rinderpest virus. Vaccine 13:36–40
Romero CH, Barrett T, Kitching RP et al (1994) Protection of cattle against rinderpest and lumpy skin disease with a recombinant capripoxvirus expressing the fusion protein gene of rinderpest virus. Vet Rec 135:152–154
Romero CH, Barrett T, Chamberlain RW et al (1994) Recombinant capripoxvirus expressing the hemagglutinin protein gene of rinderpest virus: protection of cattle against rinderpest and lumpy skin disease viruses. Virology 204:425–429. doi:10.1006/viro.1994.1548
Romero CH, Barrett T, Evans SA et al (1993) Single capripoxvirus recombinant vaccine for the protection of cattle against rinderpest and lumpy skin disease. Vaccine 11:737–742
Mulligan RC, Berg P (1981) Selection for animal cells that express the Escherichia coli gene coding for xanthine-guanine phosphoribosyltransferase. Proc Natl Acad Sci U S A 78:2072–2076
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this protocol
Cite this protocol
Boshra, H., Cao, J., Babiuk, S. (2016). Generation of Recombinant Capripoxvirus Vectors for Vaccines and Gene Knockout Function Studies. In: Brun, A. (eds) Vaccine Technologies for Veterinary Viral Diseases. Methods in Molecular Biology, vol 1349. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-3008-1_10
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3008-1_10
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-3007-4
Online ISBN: 978-1-4939-3008-1
eBook Packages: Springer Protocols